000 | 01410 a2200433 4500 | ||
---|---|---|---|
005 | 20250511175115.0 | ||
264 | 0 | _c19930316 | |
008 | 199303s 0 0 eng d | ||
022 | _a0340-6245 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAndreotti, F | |
245 | 0 | 0 |
_aVon Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction. _h[electronic resource] |
260 |
_bThrombosis and haemostasis _cDec 1992 |
||
300 |
_a678-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
650 | 0 | 4 |
_aCreatine Kinase _xblood |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIsoenzymes |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xblood |
650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xblood |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
650 | 0 | 4 |
_avon Willebrand Factor _xanalysis |
700 | 1 | _aHackett, D R | |
700 | 1 | _aHaider, A W | |
700 | 1 | _aRoncaglioni, M C | |
700 | 1 | _aDavies, G J | |
700 | 1 | _aBeacham, J L | |
700 | 1 | _aKluft, C | |
700 | 1 | _aMaseri, A | |
773 | 0 |
_tThrombosis and haemostasis _gvol. 68 _gno. 6 _gp. 678-82 |
|
999 |
_c1294411 _d1294411 |